How adults with type 1 diabetes experience the physical activity mode of their hybrid closed-loop insulin system.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, non-interventional descriptive study at CHU Grenoble Alpes using a self-administered questionnaire to capture patient-reported satisfaction with the physical activity mode of hybrid closed-loop insulin systems. Eligible participants are adults (≥18 years) with type 1 diabetes who have used a closed-loop system for at least four months and are followed at the center. The primary outcome is a satisfaction score derived from the questionnaire, with additional descriptive analyses of experience and usage patterns. The study excludes people who object to participation and those legally protected from research involvement.

Why it matters

Who can join: the full rules

Inclusion Criteria

* Age ≥ 18 years
* Patient living with type 1 diabetes
* Patient using a closed-loop system for at least 4 months
* Patient followed by a diabetologist in our center

Exclusion criteria

* People opposed to the research
* People protected by the law

Where it's running

• CHU Grenoble Alpes
  Grenoble, France Recruiting

Study contacts

• Study coordinator: Quentin Perrier, PharmD, phD
• Email: qperrier@chu-grenoble.fr
• Phone: +33 4 76 76 55 16

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New virtual care pathway for older adults with chronic diseases

  A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.

  Recruiting National University of Malaysia · Kuala Lumpur · NCT07843238

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Improving Care for underserved older Black patients with cardiovascular and other chronic conditions

  This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07748858

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes

  A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07696273

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.